Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-2144-2010

Halobag EVA Dual-Chamber Bag, Sterile R, 3000 mL Total Volume W/500 mL upper chamber, Order No. REF: 341...

Baxter Corporation Englewood / initiated 2010-05-26 / Terminated / root cause: manufacturing process

Baxa Corporation began a recall of Halobag EVA Dual-Chamber Bag, Sterile R, 3000 mL Total Volume W/500 mL upper chamber, Order No. REF: 341, Baxa Corporation on . The reason FDA records is "Fill port cap on TPN bags may become detached prior to use, thus compromising the sterility of the fluid pathway". As of , the recall status on record is Terminated, and MDM tags the root cause as manufacturing process.

Recall record

Recall number
Z-2144-2010
Status
Terminated
Initiated
Posted
Terminated
Recalling firm
Baxter Corporation Englewood
Product
Halobag EVA Dual-Chamber Bag, Sterile R, 3000 mL Total Volume W/500 mL upper chamber, Order No. REF: 341, Baxa Corporation.
Product code
KPE Container, I.V.
Reason for recall
Fill port cap on TPN bags may become detached prior to use, thus compromising the sterility of the fluid pathway.
Root cause tag
manufacturing process
FDA root cause
Process design
Action
Consignees were notified by e-mail and Baxa Bag Product Notice letter on 05/26/2010 with instructions to not use any bags if the fill port cap is detached. Photos of a detached cap and properly attached cap were included. Defective bags could be returned to Baxa for credit. Information available at 800-678-2292.
Quantity in commerce
67,800 bags
Distribution
Worldwide distribution, including USA, Argentina, Australia, Bermuda, Brazil, Canada, China, Colombia, Hong Kong, Malaysia, Mexico, New Zealand, Pakistan, Panama, South Korea, Taiwan, United Kingdom, and Uruguay.
Product codes and lots
All lot numbers